Frontiers in Oncology (Mar 2024)
Corrigendum: CLEC12A sensitizes differentially responsive breast cancer cells to the anti-cancer effects of artemisinin by repressing autophagy and inflammation
Abstract
No abstracts available.Keywords
Frontiers in Oncology (Mar 2024)